1. The role of cardioprotection in cancer therapy cardiotoxicity: JACC: CardioOncology state-of-the-art review;Omland;J Am Coll Cardiol CardioOnc,2022
2. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);Lyon;Eur Heart J,2022
3. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry;Lopez-Sendon;Eur Heart J,2020
4. Longitudinal right ventricular systolic function changes in breast cancer patients treated with cardiotoxic cancer therapy;Demissei;J Am Coll Cardiol CardioOnc,2022
5. The quest for an early marker of anthracycline-induced cardiotoxicity;Ibanez;J Am Coll Cardiol Basic Trans Science,2022